Literature DB >> 10826919

Pretreatment with methylprednisolone protects the isolated rat heart against ischaemic and oxidative damage.

G Valen1, T Kawakami, P Tähepôld, J Starkopf, C Kairane, A Dumitrescu, C Löwbeer, M Zilmer, J Vaage.   

Abstract

Methylprednisolone (MP), a synthetic glucocorticoid, is widely used clinically and experimentally as acute antiinflammatory treatment. The molecular actions of MP indicate that pretreatment with this drug may be cardioprotective. We investigated if giving rats MP prior to excising their hearts for Langendorff-perfusion protected cardiac function against oxidative stress, and if this was mediated by increasing antioxidant defence or influencing myocardial nitric oxide synthase (NOS). Rats (n=6-11 in each group) were injected with MP (40mg/kg i.m.) or vehicle 24 and 12 h before Langendorff-perfusion with 30 min global ischaemia and 60 min reperfusion, or 10 min perfusion with 180 micromol/L hydrogen peroxide. Other hearts were exposed to 30 min global ischaemia 5 days after MP-injection. Additional hearts were sampled before, during, and after ischaemia for analyzing tissue activity of antioxidant enzymes. Tissue endothelial and inducible NOS (eNOS and iNOS) were investigated by immunoblotting and semiquantitative RT-PCR in a time-course after MP injection. Pretreatment with MP improved left ventricular function and increased coronary flow during postischaemic reperfusion, and this effect was sustained 5 days afterwards. When exposing hearts to hydrogen peroxide, MP improved coronary flow. Catalase, glutathione peroxidase, and oxidized glutathione were increased during reperfusion of MP-treated hearts compared to vehicle only. MP did not influence eNOS at protein or mRNA level. iNOS could not be detected by immunoblotting, indicating low cardiac enzyme content. Its mRNA initially increased the first hour after injection, thereafter decreased. In conclusions, pretreating rats with MP protects the heart against ischaemia-reperfusion dysfunction. This effect could be due to increase of tissue antioxidant activity during reperfusion. MP did not influence cardiac eNOS. mRNA for iNOS was influenced by MP, but the corresponding protein could not be detected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10826919     DOI: 10.1080/10715760000300591

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  5 in total

1.  Corticosteroids and aldose reductase inhibitor Epalrestat modulates cardiac action potential via Kvβ1.1 (AKR6A8) subunit of voltage-gated potassium channel.

Authors:  Jared Tur; Sachin L Badole; Feng Cheng; Aparoop Das; Rakesh C Kukreja; Srinivas M Tipparaju
Journal:  Mol Cell Biochem       Date:  2017-06-05       Impact factor: 3.396

2.  Japanese herbal medicine, Saiko-keishi-to, prevents gut ischemia/reperfusion-induced liver injury in rats via nitric oxide.

Authors:  Yoshinori Horie; Mikio Kajihara; Shuka Mori; Yoshiyuki Yamagishi; Hiroyuki Kimura; Hironao Tamai; Shinzo Kato; Hiromasa Ishii
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

3.  Glucocorticoid modulates angiotensin II receptor expression patterns and protects the heart from ischemia and reperfusion injury.

Authors:  Qin Xue; Andrew J Patterson; Daliao Xiao; Lubo Zhang
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

4.  A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass.

Authors:  Davinia E Withington; Patricia S Fontela; Karen P Harrington; Christo Tchervenkov; Larry C Lands
Journal:  Springerplus       Date:  2014-08-29

Review 5.  Oxidative Stress after Surgery on the Immature Heart.

Authors:  Daniel Fudulu; Gianni Angelini
Journal:  Oxid Med Cell Longev       Date:  2016-03-31       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.